Novartis Institutes Controller Salary | Comparably
NIBR takes a unique approach to pharmaceutical research. At the earliest stages, patient need and disease determine research priorities. read more
EMPLOYEE
PARTICIPANTS
6
TOTAL
RATINGS
117

Novartis Institutes Controller Salary

The average Novartis Institutes Controller earns an estimated $102,897 annually. Novartis Institutes' Controller compensation is $20,381 less than the US average for a Controller.

The Finance Department at Novartis Institutes earns $20,356 more on average than the Admin Department.

Last updated 2 years ago.

$47k
$71k
$95k
$118k
$180k
$240k
$300k
$102,897
Average Compensation
$102,897
avg. base

Controller Salaries at Novartis Institutes

Controllers earn $2,611 more than Accounting Managers.

Accounting Manager
$100k*
Financial Analyst
$91k*
Senior Accountant
$89k*
Business Analyst
$72k*
Accountant
$63k*
* estimated salary

Compensation at Novartis Institutes by Department

The Finance Department averages $20,356 more than the Admin Department, and $5,297 less than the Business Development Department

Business Development
$80,753 Avg. total comp.
+$5k
Finance
$75,456 Avg. total comp.
Admin
$55,100 Avg. total comp.
-$20k

Controller Compensation by Gender (All Companies)

The average female Controller at companies similar size to Novartis Institutes reported making $75,250, while the average male Controller at similar sized companies reported making $119,236.

Controller Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Controller at companies similar size to Novartis Institutes reported making $137,250, while the average Caucasian Controller at similar sized companies reported making $113,399.

How Controllers at Novartis Institutes Rate Their Compensation

The majority of Controllers at Novartis Institutes believe they're compensated fairly. 100% of Controllers at Novartis Institutes say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Novartis Institutes

×
Rate your company